|
|
 |
|
Viewing report
|
|
 |
 |
Other OTC Healthcare Products Market in France to 2014 (OTC Healthcare)
Datamonitor, Feb 2011, Pages: 28
Introduction
This databook provides key data and information on the Other OTC Healthcare Products Market in France (OTC Healthcare). This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods.
Scope
-Market,category and segment level information on value, volume, and expenditure & consumption, with historic (2003-2008) and forecast (2009-2013) data -Category level company and brand share as well as distribution share information for 2007 and 2008
Highlights
The other OTC healthcare products category was valued at €381.9m ($559.4m) in 2009, representing a CAGR of 5.1% since 2004.
By the end of 2014, the other OTC healthcare products category will be worth €463m ($678.2m), with an expected CAGR of 3.9% between 2009 and 2014.
The other OTC healthcare products market was led by anti-smoking aids (representing 37.2% of the total value) followed by eye / ear drops and rectal medications, with a 31% and 14.7% market share, respectively. Sleeping aids and motion sickness constitute the remaining segments with a 13.2% and 4% market share, respectively.
GlaxoSmithKline Plc is the market leader with a 16.2% share of the market
Reasons to Purchase
-Develop business strategies by understanding the quantitative trends within the Other OTC Healthcare Products Market in France (OTC Healthcare)
-Design effective marketing and sales strategies by identifying key market categories and segments
-Identify key players within the market to plan lucrative M&A, partnerships and agreements
|
 |
|
|